An Observational Clinical Study on the Intestinal Flora in Circadian Rhythm Disorder and Healthy Controls
NCT ID: NCT05694481
Last Updated: 2023-01-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2023-01-31
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Circadian Rhythm Dysregulation in Offspring of Parents With Bipolar Disorder
NCT03656302
Effects of Sex Hormones on Circadian Rhythm in Men and Women
NCT00001285
Microbiota Profiles in Newly Married Couples: Potential Effects on Vision, Sleep and Psychometric Parameters
NCT06638606
Evaluation of Different Psychiatric Symptoms in Patients With Thyroid Dysfunction
NCT06185309
The Study of Serum Melatonin Rhythm Levels in Patients With Major Depressive Disorder
NCT01357083
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Data management The case report form ( CRF ) is a way of recording clinical data in clinical trials. The researchers should record all the relevant data of each subject in the experiment in a timely and true manner, and make confirmation and signature. CRF should not be changed at will. Researchers should sign and indicate the date when they do need to change. After the end of the trial, CRF was preserved by the clinical trial institution and sponsor of the researcher 's hospital. The completed CRF is reviewed by the clinical inspector and data entry is performed without modification. In order to ensure the privacy of subjects, the names of subjects on CRF need to use codes.
2. Statistical analysis The statistical analysis plan should be formulated after the finalization of the plan and finalized before the database is locked. The statistical analysis plan will specify and describe all the statistical analysis contents according to the main characteristics of the plan.
3. Preservation of data All clinical data and data analysis were recorded and managed by researchers.
4. Ethics Committee : Ethics Committee of Army Characteristic Medical Center of PLA. Application procedure : fill in the application form of ethical approval and attach the relevant approval materials.
5. Informed consent : The investigator must explain to each participant the nature, purpose, procedure, expected time, potential risks and benefits, and any discomfort that may arise, of the trial. Each subject must know that participation in the trial is voluntary and that he / she can withdraw from the trial at any time and withdraw his / her informed consent without affecting his / her subsequent treatment or relationship with the treating hysician. After explaining the basic content of the test and the researchers have been convinced that each participant will understand the purpose of the test, each participant should be required to sign the name and date on the informed consent form. Subjects should read and consider their tatements before signing and dated, and should obtain a copy of the informed consent form after signing. Subjects could not enter the trial without informed consent and without signed informed consent.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Circadian rhythm disorders
Observational, no intervention administered.
No interventions assigned to this group
Healthy controls
Observational, no intervention administered.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Regular night shift or day shift,
3. No antibiotics and probiotics within one month,
4. Possess understanding and communicate ability;no severe disease,no mental disorders,
5. Fully informed consent, willing to participate in this study.
Exclusion Criteria
2. Patients with severe cognitive impairment or mental illness,
3. Alcohol and drug dependence,
4. The sleep disorder by alcohol and Coffee and/or Strong tea,
5. No other Tranquilizers treatment was received within 1 week before the drug was used in this clinical trial,
6. Severe intestinal infection, such as salmonella, shigella, pestis, etc,
7. Pregnant or lactating women,
8. Other reasons not suitable for clinical trial.
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Third Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanling Wei
Associate chief physician / Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yanling Wei*, MD
Role: PRINCIPAL_INVESTIGATOR
Daping Hospital, Army medical university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Daping Hospital, The Third Military Medical University
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20221201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.